Health

Vera Therapeutics Kidney Drug Approval

Updated 2026-07-08 13:25 UTC 1 source Neutral

The FDA approved Trutakna from Vera Therapeutics for the treatment of IgA nephropathy. This approval comes as some employers are finding ways to avoid expanding coverage of GLP-1 obesity drugs.

Coverage timeline — 1 article

STAT News

STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more

The FDA approved a kidney disease drug from Vera Therapeutics called Trutakna, to treat IgA nephropathy

2026-07-08 13:11 UTC